ClinicalTrials.gg
Active, not recruitingNCT06925165Updated Apr 13, 2025

Ultrasound Measured Hyomental Distance to Tongue Thickness Ratio as a Predictor of Difficult Intubation in Infants

An observational study in Ultrasound, sponsored by Ain Shams University. Active, not recruiting at 1 site in Egypt. Open to participants aged 1 Month to 12 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-13.

Sponsored by Ain Shams University · Observational

From the registry’s dates

  • Primary completion was expected by Jul 2025, 1 year 2 months ago, but the record still lists the study as active, not recruiting.
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
50
Ages
1 Month to 12 Months
Sex
All
01

Study summary

Evaluation the role of ultrasound measured hyomental distance to tongue thickness ratio in predicting difficult intubation in infants

Read the detailed description

Sonographic assessment of the airway after induction of anesthesia and Master Degree Thesis / MFA/ISRO/ Faculty Of Medicine/ASU Page 6 intubation: All infants will be placed in a supine position with their heads slightly extended. Then, the low-frequency probe (curved) will be first placed under the chin in the midsagittal plane and adjusted to show a clear view of the entire tongue outline and the border of the mandible and hyoid bone on the screen. The image will be frozen and stored. On the image the tongue thickness will be measured, which is the maximum vertical distance from the sub mental skin to the tongue surface (Yao W, Wang B 2017). After that, the HMDE will be measured, which is the distance from the lower border of the mentum of the mandible to the upper border of the hyoid bone.

02

Conditions studied

  • Ultrasound
03

In context

Lead sponsor

Ain Shams University is the lead sponsor of 1,932 studies on the registry; 433 are open to participants now.

Of its 33 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Month to 12 Months
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Infants aged 1 to 12 months

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Infants aged 1 to 12 months

Both sexes.

Physical status ASA I or II

Exclusion criteria

Exclusion Criteria:

  • Restricted mobility of temporomandibular joint
  • Absent anesthesia or surgical consent
  • Maxillofacial trauma or tumors
  • A large mass or scar under the chin
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
50 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. role of ultrasound measured hyomental distance to tongue thickness ratio in predicting difficult intubation in infants.

    Difficult intubation can be a significant life threatening problem in anesthesia which can lead to serious complications like hypoxia, aspiration, esophageal intubation, emergency surgical airway, cardiovascular instability, cardiac arrhythmias, ischemic encephalopathy, and death. In the study investigators will use hyomental distance and tongue thickness measured by ultrasound to suspect difficult intubation in infants aged 1 to 12 month.

    Time frame: 2 to 3 minutes after induction of anaesthesia and intubation

07

Study locations

1 site
  • Ain Shams University
    Cairo, Egypt 11111, Egypt
08

References and documents

Individual participant data

Plan to share: Yes — all data will be shared once study is completed

Time frame: before 1/2026

Access criteria: free

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2025 (actual). Primary completion is estimated for Jul 2025, 6 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 6, 2025
First posted
Apr 13, 2025
StartActual
Jan 29, 2025
Primary completionEst.
Jul 29, 2025
CompletionEst.
Jul 29, 2025
Last update
Apr 13, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 13, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06925165
Responsible party
Sponsor
First posted
Apr 13, 2025
Start date
Jan 29, 2025
Primary completion
Jul 29, 2025 (estimated)
Completion
Jul 29, 2025 (estimated)
Last update
Apr 13, 2025

Study contacts

Shaimaa Reda Ahmed, MBBCH
principal investigator · Anesthesia resident Ain Shams University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion